On September 24, 2026, HELLO! published a practical dermatology feature on sensitive skin and eczema around hormonal transitions, including perimenopause. Consultant dermatologists Dr Ellie Rashid and Dr Jonathan Guckian discussed possible hormonal contributions to skin flares alongside other triggers and the need for medical care when inflammation persists.
Barrier care and medical assessment remain the foundation
The established approach described by the American Academy of Dermatology puts fragrance-free moisturiser and assessment of lasting or worsening skin problems at the centre of care. A rash is not simply a signal to add another skincare product. The academy advises seeing a board-certified dermatologist when a rash lasts or a skin condition worsens.
The HELLO! feature adds hormonal context to those care priorities rather than replacing them. Its practical focus is on recognising patterns and reducing irritation without overlooking inflammation that needs treatment. For midlife women, the useful shift is a fuller conversation about possible contributors rather than a new label applied to every uncomfortable patch of skin.
The report separates hormonal clues from inflammatory symptoms
This is reported expert advice, not a clinical trial or a formal guideline update. The feature does not quantify the hormonal effect or establish that hormones caused an individual’s rash. Repeated timing can suggest a connection but cannot prove one. The sources also do not establish how common menopause-related eczema is or show that a particular anti-aging ingredient causes it.
Hormonal change belongs beside other possible triggers
- The skin barrier offers a possible biological link. Rashid explains that oestrogen helps skin retain water and produce barrier lipids and ceramides. When oestrogen drops, she says skin can become drier and lose water more easily. That can leave it more reactive. Her explanation places hormonal change within skin physiology rather than treating every flare as a separate hormonal disorder.
- Eczema may appear or return around the menopause transition. Rashid identifies this transition as one period when eczema can first appear or recur. Cleveland Clinic also describes possible new atopic dermatitis symptoms or more frequent flares during perimenopause and menopause. These accounts support including life stage in a skin-health conversation.
- Other factors belong in the same picture. The HELLO! report names poor sleep and stress alongside products and other irritants as possible contributors. Detergents and foods may also coincide with episodes. Rashid notes that scratching can compound inflammation or barrier damage. The report gives more weight to a possible hormonal contribution when a similar timing pattern repeats.
The editorial takeaway is to keep the explanation broad enough to fit the evidence. Hormonal timing deserves attention without crowding out a recent product change or a stressful period. Refemina’s coverage of the physiology behind midlife skin changes places these questions within the wider picture of skin health rather than treating appearance and discomfort as unrelated concerns.
Sensitivity and eczema describe different things
- Sensitive skin describes a response. The HELLO! feature describes stinging or burning alongside tightness or redness after exposure to products or the environment. The skin may look fairly normal. This language captures discomfort that deserves attention without automatically naming a particular inflammatory condition.
- Eczema involves visible inflammation. The report describes dry or rough itchy patches and sometimes bumps. Weeping skin or thickening from scratching may also occur. Sensitivity and eczema can overlap, but they are not interchangeable descriptions. Visible changes and the character of the discomfort are useful details to bring to a clinical conversation.
That distinction changes the question from whether the skin is simply more sensitive to what is actually happening on it. A description of burning after a product is different from a description of persistent itchy patches. Neither needs to be minimised. The point is to use language that helps a clinician assess the problem rather than adopting a hormonal explanation before the skin has been evaluated.
A diary gives the consultation more useful detail
Rashid recommends a simple diary for at least two to three months to help identify patterns. Her suggestion brings skin symptoms and possible triggers into one record. It is not an elaborate skincare audit or a test that requires buying anything. The useful material is the information that helps compare one episode with another.
- Record relevant dates. Rashid suggests noting menstrual cycle dates and dates related to hormone replacement therapy or IVF where applicable. These are observations for discussion with a clinician, not a reason to change a prescribed treatment independently.
- Describe the skin and the itch. Her proposed record includes skin appearance and itch severity. A consistent description keeps the focus on what changed rather than a general impression that the skin has become difficult.
- Include the surrounding circumstances. Sleep and stress belong beside new products or detergents in the diary. The report also includes new foods among the details to record. Recording a possible association is different from treating it as an established trigger.
- Use comparable photographs. Rashid suggests a weekly photograph taken in the same light. This gives the conversation a visual record alongside the written account without requiring a complicated tracking system.
The diary’s role is to organise observations, not to create a waiting period before assessment. Sleep-disrupting itch and the other symptoms described below still warrant medical attention. For the broader midlife context, Refemina also covers sleep during the hormonal transition. Here, sleep is one part of the record rather than an explanation that should displace the skin symptoms themselves.
A simpler routine is the reported response to irritation
- Guckian favours a gentle cleanser and fragrance-free moisturiser. His advice in HELLO! is a barrier-first approach during irritation rather than layering more products. The American Academy of Dermatology also recommends fragrance-free moisturiser for menopausal skin. The common thread is supportive care with less emphasis on adding products.
- Products that consistently sting or irritate deserve attention. Guckian advises pausing these products during irritation. The feature names exfoliating acids and scrubs among potentially irritating products on affected skin. It also cautions about fragrance and possibly retinoids. This is advice about irritated skin, not a blanket judgment on every active ingredient.
- Natural fragrance is not automatically gentler. The HELLO! report cautions that fragrance from natural sources can also be problematic. Its practical message is to focus on irritation rather than assuming that a natural label makes a product suitable for a flare. Marketing language is not a substitute for noticing how affected skin responds.
For women interested in skincare and appearance, this need not be framed as choosing between comfort and caring about how the skin looks. Those concerns can sit together. During irritation, the feature’s emphasis shifts from adding actives to supporting the barrier. Personal decisions about a routine belong with a qualified clinician when the skin problem is persistent or its nature is unclear.
Persistent inflammation needs more than a product decision
- The feature identifies symptoms that warrant assessment. Persistent itchy patches and itch that disturbs sleep are reasons to seek medical advice. Broken or weeping skin also belongs in that conversation. These are the report’s care-seeking signals, not symptoms to explain away as an ordinary part of perimenopause.
- The academy advises assessment of lasting or worsening problems. The American Academy of Dermatology recommends seeing a board-certified dermatologist if a rash lasts or a skin condition worsens. It also notes that skin may become drier and more sensitive around menopause and that existing eczema may worsen.
- Moisturising may not settle every flare. Guckian says emollients support the barrier but some inflammatory flares need prescribed treatment. He describes doctor-supported topical steroids or another prescribed treatment as possible options. Choosing a treatment for an individual flare belongs with a qualified clinician.
The consultation can bring together the appearance of the skin and the impact of itch alongside the diary’s timing information. This keeps the discussion grounded in both symptoms and daily life. Refemina’s coverage of eczema across different life stages offers related context. A menopause connection is worth discussing without allowing it to become the entire assessment.
Clinical conversations should include timing without replacing assessment
The useful direction for clinical practice is to place hormonal timing alongside other triggers while keeping barrier care and assessment of persistent inflammation at the centre.
How Refemina helps
Midlife skin irritation calls for explanations that leave room for hormonal change without making it the answer to every flare. Refemina addresses that uncertainty through research-led coverage connecting skin concerns with the wider hormonal transition, helping women understand possible contributors and separate evidence from anti-aging marketing without reducing their experience to a single cause.
Explore Resources
Sources
- Why Atopic Dermatitis Can Change Throughout Your Life
- Is your sensitive skin actually hormonal eczema
- Caring for your skin in menopause - American Academy of ...
